Stuart Duty's most recent trade in Milestone Pharmaceuticals Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 50,000 | 50,000 | - | - | Stock Options (Right to buy) | |
| EyePoint Pharmaceuticals Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Milestone Pharmaceuticals Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Milestone Pharmaceuticals Inc | Stuart M. Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Stuart Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| EyePoint Pharmaceuticals Inc | Stuart Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Stuart Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) |